Celera Genomics to Acquire Axys Pharmaceuticals, Inc.; Merger Expected to Advance Drug Discovery Capabilities for Celera.
Linked as:
Extract
Celera Genomics to Acquire Axys Pharmaceuticals, Inc.; Merger Expected to Advance Drug Discovery Capabilities for Celera.
Business Editors, Health/Medical Writers
ROCKVILLE, Md. & SOUTH SAN FRANCISCO, Calif. --(BW HealthWire)-- June 13, 2001 Celera Genomics (NYSE:CRA), an Applera Corporation business, and Axys Pharmaceuticals, Inc. (Nasdaq:AXPH), a biopharmaceutical company with expertise in the development of small molecule therapeutics, announced today that they have signed a definitive merger agreement whereby Celera will acquire Axys in a stock-for-stock transaction. The capabilities expected to be acquired through this merger should support and accelerate Celera's expansion into the drug discovery arena. The transaction, which has been unanimously approved by the Boards of Directors of both companies, is structured as a ta...See the full content of this document
Sponsored links
